[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![HighSell53466 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1937749820602753024.png) Buy High Sell Low [@HighSell53466](/creator/twitter/HighSell53466) on x XXX followers
Created: 2025-07-21 11:22:13 UTC

$VKTX is riding the GLP-1 wave—but with a twist.
Their dual agonist approach targets both weight loss and NASH, aiming for best-in-class efficacy.
If the science holds, this isn’t just another “me too” play—it’s a leapfrog.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947255790420562111/c:line.svg)

**Related Topics**
[weight loss](/topic/weight-loss)
[$vktx](/topic/$vktx)

[Post Link](https://x.com/HighSell53466/status/1947255790420562111)